Kent Edward Kester's most recent trade in Turn Therapeutics Inc. was a trade of 83,334 Stock option (right to buy) done . Disclosure was reported to the exchange on June 4, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Turn Therapeutics Inc | Kent Edward Kester | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2026 | 83,334 | 83,334 | - | - | Stock option (right to buy) | |
| Turn Therapeutics Inc | Kent Edward Kester | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Oct 2025 | 10,000 | 10,000 | - | 0 | Common Stock |